PERBANDINGAN EFEKTIVITAS BIAYA PEMBERIAN OBAT SEFTRIAKSON DAN LEVOFLOKSASIN PADA PASIEN PNEUMONIA DEWASA DI INSTALASI RAWAT INAP RSPAD GATOT SOEBROTO

• Main Author: Muhamad Iqbal Husaini, (Author)
• Format: Book
• Published: 2024-01-09.
• Subjects: Thesis; NonPeerReviewed
• Online Access: Link Metadata

Summary

Pneumonia is a respiratory infection that affects 450 million people and kills 7% of them worldwide. It is a major problem in Indonesia, especially Jakarta, where 2.2% of the population had pneumonia in 2021. Levofloxacin and ceftriaxone are common antibiotics for pneumonia. This study compares their cost-effectiveness using a cross-sectional observational analysis of medical data and patient costs from January 2022 to September 2023. Ceftriaxone therapy was cheaper but not significantly different from levofloxacin therapy (p = 0.944). Levofloxacin reduced leukocytes more than ceftriaxone (p = 0.033). Levofloxacin therapy had a lower ACER value of IDR 1,410.58 than ceftriaxone therapy. Switching from ceftriaxone to levofloxacin cost IDR 64.00 more per 1 μL leukocyte reduction. Levofloxacin was more cost-effective than ceftriaxone for pneumonia patients at RSPAD Gatot Soebroto.

Item Description

http://repository.upnvj.ac.id/28281/2/ABSTRAK.pdf
http://repository.upnvj.ac.id/28281/12/AWAL.pdf
http://repository.upnvj.ac.id/28281/3/BAB%201.pdf
http://repository.upnvj.ac.id/28281/4/BAB%202.pdf
http://repository.upnvj.ac.id/28281/5/BAB%203.pdf
http://repository.upnvj.ac.id/28281/6/BAB%204.pdf
http://repository.upnvj.ac.id/28281/7/BAB%205.pdf
http://repository.upnvj.ac.id/28281/8/DAFTAR%20PUSTAKA.pdf
http://repository.upnvj.ac.id/28281/9/RIWAYAT%20HIDUP.pdf
http://repository.upnvj.ac.id/28281/10/LAMPIRAN.pdf
http://repository.upnvj.ac.id/28281/11/HASIL%20PLAGIARISME.pdf
http://repository.upnvj.ac.id/28281/1/ARTIKEL%20KI.pdf